Simplex Trading
FBRX icon

Simplex Trading’s Forte Biosciences FBRX Stock Holding History

Simplex Trading’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$907K Buy
+35,000
New +$1.01M ﹤0.01% 2611
2024
Q1 		– Sell
-616
Closed -$12K – 9135
2023
Q4 		$12K Sell
616
-136
-18% -$1.9K ﹤0.01% 7289
2023
Q3 		$12K Buy
752
+132
+21% +$2.93K ﹤0.01% 7037
2023
Q2 		$16K Buy
620
+28
+5% +$727 ﹤0.01% 6970
2023
Q1 		$14K Sell
592
-1,172
-66% -$29.5K ﹤0.01% 7241
2022
Q4 		$44K Sell
1,764
-20
-1% -$513 ﹤0.01% 6032
2022
Q3 		$47K Buy
1,784
+384
+27% +$12.2K ﹤0.01% 6530
2022
Q2 		$45K Sell
1,400
-72
-5% -$2.29K ﹤0.01% 6640
2022
Q1 		$53K Sell
1,472
-552
-27% -$20.9K ﹤0.01% 7044
2021
Q4 		$108K Buy
+2,024
New +$136K ﹤0.01% 6133
2020
Q3 		– Hold
0
– -$5K – 7983
2020
Q2 		– Hold
0
– – – 6964
2020
Q1 		– Hold
0
– – – 6665
2019
Q4 		– Sell
-1
Closed -$227 – 7087
2019
Q3 		$14K Buy
+1
New +$1.52K ﹤0.01% 6050
2019
Q2 		– Hold
0
– – – 4963
2019
Q1 		– Hold
0
– – – 4857
2018
Q4 		– Hold
0
– – – 5966
2018
Q3 		– Hold
0
– – – 5946
2018
Q2 		– Hold
0
– – – 4250

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Simplex Trading's FBRX Position: Q1 2026 in Review

Simplex Trading reduced its Forte Biosciences (FBRX) stake by 62% in Q1 2026, selling an estimated $107K and leaving 2,312 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5672.

Simplex Trading first reported a position in FBRX in Q4 2017 and has held it in 11 quarters since. The position peaked at $187K in Q1 2019. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Simplex Trading held 2,312 shares of Forte Biosciences worth $59.9K as of Q1 2026.
  • Simplex Trading sold 3,703 Forte Biosciences shares in Q1 2026, an estimated $107K.
  • Forte Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5672 holding.
  • Simplex Trading first reported a position in Forte Biosciences in Q4 2017 and has held it in 11 quarters since.
  • Simplex Trading's Forte Biosciences position peaked at $187K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.